Tigecycline
Back to searchMolecule Structure
Scientific Name
Tigecycline
Description of the Drug
Tigecycline is a glycylcycline antibiotic used to treat a number of susceptible bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00560
http://www.drugbank.ca/drugs/DB00560
Brand Name(s)
Tigecycline, Tygacil
Company Owner(s)
Apotex Inc, Fresenius Kabi Usa Llc, Sandoz Inc, Eugia Pharma Specialities Ltd, Xellia Pharmaceuticals Aps, Meitheal Pharmaceuticals Inc, Accord Healthcare Inc Usa, Amneal Pharmaceuticals Llc, Pf Prism Cv
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL101795 | |
| Human Metabolome Database | HMDB0014700 | |
| DrugBank | DB00560 | |
| PubChem: Thomson Pharma | 14862434 | |
| NMRShiftDB | 60027691 | |
| Nikkaji | J1.112.522K | |
| BindingDB | 50247905 | |
| EPA CompTox Dashboard | DTXSID2048581 | |
| DrugCentral | 2661 | |
| Metabolights | MTBLC149836 | |
| ChemicalBook | CB6248215 | |
| rxnorm | TYGACIL | TIGECYCLINE |
| PubChem: Drugs of the Future | 12014912 | |
| KEGG Ligand | C12012 | |
| ChEBI | 149836 | |
| ZINC | ZINC000014879972 |
